rs116717961

Variant summary

Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBS1BS2

The NM_004393.6(DAG1):​c.259A>G​(p.Ile87Val) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0104 in 1,614,076 control chromosomes in the GnomAD database, including 113 homozygotes. In-silico tool predicts a benign outcome for this variant. 14/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★★). Synonymous variant affecting the same amino acid position (i.e. I87I) has been classified as Likely benign.

Frequency

Genomes: 𝑓 0.0079 ( 7 hom., cov: 31)
Exomes 𝑓: 0.011 ( 106 hom. )

Consequence

DAG1
NM_004393.6 missense

Scores

3
14

Clinical Significance

Benign/Likely benign criteria provided, multiple submitters, no conflicts B:7O:1

Conservation

PhyloP100: 2.26

Publications

8 publications found
Variant links:
Genes affected
DAG1 (HGNC:2666): (dystroglycan 1) This gene encodes dystroglycan, a central component of dystrophin-glycoprotein complex that links the extracellular matrix and the cytoskeleton in the skeletal muscle. The encoded preproprotein undergoes O- and N-glycosylation, and proteolytic processing to generate alpha and beta subunits. Certain mutations in this gene are known to cause distinct forms of muscular dystrophy. Alternative splicing results in multiple transcript variants, all encoding the same protein. [provided by RefSeq, Nov 2015]
DAG1 Gene-Disease associations (from GenCC):
  • autosomal recessive limb-girdle muscular dystrophy type 2P
    Inheritance: AR Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: G2P, Genomics England PanelApp, Orphanet
  • muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies), type A9
    Inheritance: AR Classification: DEFINITIVE, STRONG Submitted by: Labcorp Genetics (formerly Invitae), G2P
  • muscular dystrophy-dystroglycanopathy, type A
    Inheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet
  • isolated asymptomatic elevation of creatine phosphokinase
    Inheritance: AD Classification: LIMITED Submitted by: Ambry Genetics

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -20 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=0.012165487).
BP6
Variant 3-49510793-A-G is Benign according to our data. Variant chr3-49510793-A-G is described in ClinVar as Benign/Likely_benign. ClinVar VariationId is 128884.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BS1
Variant frequency is greater than expected in population amr. GnomAd4 allele frequency = 0.00791 (1204/152204) while in subpopulation AMR AF = 0.0193 (295/15280). AF 95% confidence interval is 0.0175. There are 7 homozygotes in GnomAd4. There are 526 alleles in the male GnomAd4 subpopulation. Median coverage is 31. This position passed quality control check.
BS2
High Homozygotes in GnomAd4 at 7 AR,AD gene

Variant Effect in Transcripts

ACMG analysis was done for transcript: NM_004393.6. You can select a different transcript below to see updated ACMG assignments.

RefSeq Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
DAG1
NM_004393.6
MANE Select
c.259A>Gp.Ile87Val
missense
Exon 2 of 3NP_004384.5
DAG1
NM_001165928.4
c.259A>Gp.Ile87Val
missense
Exon 5 of 6NP_001159400.3
DAG1
NM_001177634.3
c.259A>Gp.Ile87Val
missense
Exon 5 of 6NP_001171105.2

Ensembl Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
DAG1
ENST00000308775.7
TSL:1 MANE Select
c.259A>Gp.Ile87Val
missense
Exon 2 of 3ENSP00000312435.2
DAG1
ENST00000479935.1
TSL:1
n.570A>G
non_coding_transcript_exon
Exon 1 of 2
DAG1
ENST00000418588.6
TSL:3
c.259A>Gp.Ile87Val
missense
Exon 3 of 4ENSP00000405859.2

Frequencies

GnomAD3 genomes
AF:
0.00791
AC:
1203
AN:
152086
Hom.:
7
Cov.:
31
show subpopulations
Gnomad AFR
AF:
0.00217
Gnomad AMI
AF:
0.00110
Gnomad AMR
AF:
0.0193
Gnomad ASJ
AF:
0.00375
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.00
Gnomad FIN
AF:
0.00453
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.0107
Gnomad OTH
AF:
0.0124
GnomAD2 exomes
AF:
0.00809
AC:
2032
AN:
251050
AF XY:
0.00761
show subpopulations
Gnomad AFR exome
AF:
0.00166
Gnomad AMR exome
AF:
0.0159
Gnomad ASJ exome
AF:
0.00417
Gnomad EAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.00610
Gnomad NFE exome
AF:
0.0107
Gnomad OTH exome
AF:
0.0114
GnomAD4 exome
AF:
0.0107
AC:
15642
AN:
1461872
Hom.:
106
Cov.:
74
AF XY:
0.0102
AC XY:
7433
AN XY:
727238
show subpopulations
African (AFR)
AF:
0.00137
AC:
46
AN:
33480
American (AMR)
AF:
0.0164
AC:
734
AN:
44720
Ashkenazi Jewish (ASJ)
AF:
0.00398
AC:
104
AN:
26134
East Asian (EAS)
AF:
0.00
AC:
0
AN:
39700
South Asian (SAS)
AF:
0.0000464
AC:
4
AN:
86252
European-Finnish (FIN)
AF:
0.00640
AC:
342
AN:
53418
Middle Eastern (MID)
AF:
0.00121
AC:
7
AN:
5768
European-Non Finnish (NFE)
AF:
0.0124
AC:
13836
AN:
1112004
Other (OTH)
AF:
0.00942
AC:
569
AN:
60396
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.474
Heterozygous variant carriers
0
938
1875
2813
3750
4688
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
550
1100
1650
2200
2750
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.00791
AC:
1204
AN:
152204
Hom.:
7
Cov.:
31
AF XY:
0.00707
AC XY:
526
AN XY:
74424
show subpopulations
African (AFR)
AF:
0.00217
AC:
90
AN:
41526
American (AMR)
AF:
0.0193
AC:
295
AN:
15280
Ashkenazi Jewish (ASJ)
AF:
0.00375
AC:
13
AN:
3466
East Asian (EAS)
AF:
0.00
AC:
0
AN:
5190
South Asian (SAS)
AF:
0.00
AC:
0
AN:
4810
European-Finnish (FIN)
AF:
0.00453
AC:
48
AN:
10600
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
292
European-Non Finnish (NFE)
AF:
0.0107
AC:
731
AN:
68012
Other (OTH)
AF:
0.0123
AC:
26
AN:
2116
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.506
Heterozygous variant carriers
0
71
142
213
284
355
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
20
40
60
80
100
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.00972
Hom.:
51
Bravo
AF:
0.00922
TwinsUK
AF:
0.0127
AC:
47
ALSPAC
AF:
0.00986
AC:
38
ESP6500AA
AF:
0.00159
AC:
7
ESP6500EA
AF:
0.0116
AC:
100
ExAC
AF:
0.00719
AC:
873
Asia WGS
AF:
0.00115
AC:
4
AN:
3478
EpiCase
AF:
0.0111
EpiControl
AF:
0.0113

ClinVar

ClinVar submissions as Germline
Significance:Benign/Likely benign
Revision:criteria provided, multiple submitters, no conflicts
View on ClinVar
Pathogenic
VUS
Benign
Condition
-
-
3
not provided (4)
-
-
2
not specified (2)
-
-
1
DAG1-related disorder (1)
-
-
1
Muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies), type A9;C4511963:Autosomal recessive limb-girdle muscular dystrophy type 2P (1)

Computational scores

Source: dbNSFP v4.9

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.080
BayesDel_addAF
Benign
-0.23
T
BayesDel_noAF
Uncertain
-0.080
CADD
Benign
15
DANN
Benign
0.87
DEOGEN2
Benign
0.32
T
Eigen
Benign
-0.28
Eigen_PC
Benign
-0.10
FATHMM_MKL
Uncertain
0.90
D
LIST_S2
Benign
0.69
T
MetaRNN
Benign
0.012
T
MetaSVM
Uncertain
0.096
D
MutationAssessor
Benign
1.6
L
PhyloP100
2.3
PrimateAI
Benign
0.47
T
PROVEAN
Benign
-0.14
N
REVEL
Benign
0.23
Sift
Benign
0.25
T
Sift4G
Benign
0.54
T
Polyphen
0.0060
B
Vest4
0.17
MVP
0.72
MPC
0.23
ClinPred
0.0052
T
GERP RS
4.3
Varity_R
0.043
gMVP
0.35
Mutation Taster
=99/1
polymorphism

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs116717961; hg19: chr3-49548226; API